Publications

Therapeutic Areas

Real-World Evidence

Newest to Oldest

Cost burden of endothelial keratoplasty in fuchs endothelial dystrophy: real-world analysis of a commercially insured US population (2014–2019)

Authors: D K Dhaliwal, V Chirikov, J Schmier, S Rege, S Newton

Effect of treating erectile dysfunction on management of systolic hypertension

Authors: Richard E Scranton 1, Elizabeth Lawler, Marc Botteman, Subha Chittamooru, David Gagnon, Robert Lew, James Harnett, J Michael Gaziano

Influence of real-world characteristics on outcomes for patients with methicillin-resistant staphylococcal skin and soft tissue infections: A multi-country medical chart review in Europe

Authors: D Nathwani, C Eckmann, W Lawson, C T Solem, S Corman, J M Stephens, C Macahilig, D Simoneau, R Chambers, J Z Li & S Haider

Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study

Authors: M Mohty, W Knauf, D Romanus, S Corman, K Verleger, Y Kwon, D Cherepanov, M J Cambron-Mellott, H G Vikis, F Gonzalez, F Gavini, K Ramasamy

Real-world treatment patterns and outcomes in non-transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom

Authors: M Mohty, W Knauf, D Romanus, S Corman, K Verleger, Y Kwon, D Cherepanov, M J Cambron-Mellott, H G Vikis, F Gonzalez, F Gavini, K Ramasamy

Continuation of systemic treatments and outcomes for patients with chronic graft-versus-host disease in the USA

Authors: X Huang, N Joshi, L Luo, N Shamseddine, X Gao

Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study

Authors: A Aly, P Singh, B Korytowsky, Y Ling, H P Kale, H B Dastani, M F Botteman, A D Norden

The real-world lifetime economic burden of urothelial carcinoma by stage at diagnosis

Authors: A Aly, C Johnson, Y Doleh, V Chirikov, M Botteman, R Shenolikar, A Hussain

Claims Data Analysis of Dosing and Cost of TNF Antagonist

Authors: N Yan Gu, X Huang, K M Fox, V D Patel, S W Baumgartner, C Chiou

Burden of irritable bowel syndrome in an increasingly cost-aware National Health Service

Authors: A Soubieres, P Wilson, A Poullis, J Wilkins, M Rance

View older